Literature DB >> 26146545

Dendrimer Conjugates for Light-activated Delivery of Antisense Oligonucleotides.

Ahu Yuan1, Yiqiao Hu2, Xin Ming3.   

Abstract

Therapeutic oligonucleotides, such as splice switching ONs (SSOs), provide opportunities for treating serious, life-threatening diseases. However, the development of ONs as therapeutic agents has progressed slowly, because difficult cytosolic delivery of SSOs into the cytosol and nucleus remains a major barrier. Photochemical internalization (PCI), a promising strategy for endosomal escape, was introduced to disrupt the endosomal membrane using light and a photosensitizer. Here we constructed Poly(amido amine) (PAMAM) dendrimer conjugates to simultaneously deliver SSOs and photosensitizers into endo/lysosomal compartments. After photo-irradiation, considerable ONs were observed to diffuse into the cytosol and accumulate in the nucleus. Furthermore, the PCI mediated cytosolic delivery of SSOs effectively enhanced their nuclear splice switching activity.

Entities:  

Keywords:  Splice switching oligonucleotides; cytosolic delivery; dendrimers; photochemical internalization; photosensitizer

Year:  2015        PMID: 26146545      PMCID: PMC4486491          DOI: 10.1039/C5RA04091D

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  25 in total

1.  Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer.

Authors:  Nobuhiro Nishiyama; Aya Iriyama; Woo-Dong Jang; Kanjiro Miyata; Keiji Itaka; Yuji Inoue; Hidenori Takahashi; Yasuo Yanagi; Yasuhiro Tamaki; Hiroyuki Koyama; Kazunori Kataoka
Journal:  Nat Mater       Date:  2005-11-20       Impact factor: 43.841

2.  Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.

Authors:  Rekha G Panchal; Bruce L Geller; Brett Mellbye; Douglas Lane; Patrick L Iversen; Sina Bavari
Journal:  Nucleic Acid Ther       Date:  2012-09-14       Impact factor: 5.486

3.  Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice.

Authors:  Jennifer Roberts; Enzo Palma; Peter Sazani; Henrik Ørum; Moo Cho; Ryszard Kole
Journal:  Mol Ther       Date:  2006-07-18       Impact factor: 11.454

4.  In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.

Authors:  James E Dahlman; Carmen Barnes; Omar Khan; Aude Thiriot; Siddharth Jhunjunwala; Taylor E Shaw; Yiping Xing; Hendrik B Sager; Gaurav Sahay; Lauren Speciner; Andrew Bader; Roman L Bogorad; Hao Yin; Tim Racie; Yizhou Dong; Shan Jiang; Danielle Seedorf; Apeksha Dave; Kamaljeet S Sandu; Matthew J Webber; Tatiana Novobrantseva; Vera M Ruda; Abigail K R Lytton-Jean; Christopher G Levins; Brian Kalish; Dayna K Mudge; Mario Perez; Ludmila Abezgauz; Partha Dutta; Lynelle Smith; Klaus Charisse; Mark W Kieran; Kevin Fitzgerald; Matthias Nahrendorf; Dganit Danino; Rubin M Tuder; Ulrich H von Andrian; Akin Akinc; Avi Schroeder; Dipak Panigrahy; Victor Kotelianski; Robert Langer; Daniel G Anderson
Journal:  Nat Nanotechnol       Date:  2014-05-11       Impact factor: 39.213

Review 5.  Targeting RNA to treat neuromuscular disease.

Authors:  Francesco Muntoni; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

6.  Anti-tumor activity of splice-switching oligonucleotides.

Authors:  John A Bauman; Shyh-Dar Li; Angela Yang; Leaf Huang; Ryszard Kole
Journal:  Nucleic Acids Res       Date:  2010-08-18       Impact factor: 16.971

7.  Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.

Authors:  Md Rowshon Alam; Vidula Dixit; Hyunmin Kang; Zi-Bo Li; Xiaoyuan Chen; Joann Trejo; Michael Fisher; Rudy L Juliano
Journal:  Nucleic Acids Res       Date:  2008-03-26       Impact factor: 16.971

8.  Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides.

Authors:  Xin Ming; Kyle Carver; Lin Wu
Journal:  Biomaterials       Date:  2013-07-19       Impact factor: 12.479

Review 9.  Development of therapeutic splice-switching oligonucleotides.

Authors:  Petra Disterer; Adrianna Kryczka; Yuqi Liu; Yusef E Badi; Jessie J Wong; James S Owen; Bernard Khoo
Journal:  Hum Gene Ther       Date:  2014-06-19       Impact factor: 5.695

10.  Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity.

Authors:  Kathryn A Whitehead; J Robert Dorkin; Arturo J Vegas; Philip H Chang; Omid Veiseh; Jonathan Matthews; Owen S Fenton; Yunlong Zhang; Karsten T Olejnik; Volkan Yesilyurt; Delai Chen; Scott Barros; Boris Klebanov; Tatiana Novobrantseva; Robert Langer; Daniel G Anderson
Journal:  Nat Commun       Date:  2014-06-27       Impact factor: 14.919

View more
  2 in total

Review 1.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

Review 2.  The Evolving Treatment of Diabetic Retinopathy.

Authors:  Sam E Mansour; David J Browning; Keye Wong; Harry W Flynn; Abdhish R Bhavsar
Journal:  Clin Ophthalmol       Date:  2020-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.